CLINICAL STUDIES
Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy
Anji T. Yetman, MDa,
Robert M. Hamilton, MDa,
Lee N. Benson, MD, FACCa and
Brian W. McCrindle, MD, FACCa
a Department of Pediatrics, Division of Cardiology, The Hospital for Sick Children, and the Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Manuscript received March 16, 1998;
revised manuscript received July 30, 1998,
accepted August 6, 1998.
Address for correspondence: Dr. Robert Hamilton, The Hospital for Sick Children, Room 1503F, 555 University Avenue, Toronto ON M5G 1X8, Canada
robert.hamilton{at}mailhub.sickkids.on.ca
Objectives. We sought to determine clinical, angiographic, and echocardiographic predictors of survival in children with isolated hypertrophic cardiomyopathy (HCM) in a large pediatric centre.
Background. Sudden death is a catastrophic outcome of HCM in childhood but has been difficult to predict. Current therapies might provide for improved outcome if factors identifying high risk can be identified.
Methods. Records of 99 patients diagnosed with HCM from 1958 to 1997 at <18 yr were reviewed for clinical, angiographic (n = 62) and echocardiographic (n = 83) predictors of survival outcome. The effects of clinical characteristics on sudden death (including resuscitated sudden death) were individually tested in Cox’s proportionate hazard modeling.
Results. Seventy-one subjects were male. Median age at diagnosis was 5.0 yr with a medical follow-up interval of 4.8 yr. Thirty-seven of 97 patients had a family history of HCM. Ambulatory electrocardiograms (ECG) in 78 patients demonstrated supraventricular tachycardia in 16 and ventricular tachycardia in 21. Death or resuscitated sudden death occurred in 18 patients. Sudden death rate was 2.7%/yr after age 8 yr. Cox’s proportionate survival modeling revealed increased corrected QT interval (QTc) dispersion on ECG (relative risk [RR] 1.61 per 20 ms increment, p < 0.0003), ventricular tachycardia (VT) on ambulatory ECG (RR 3.75, p < 0.006) and myocardial bridging of the LAD coronary (RR 12.0, p < 0.003) to be associated with reduced time to death or resuscitated sudden death.
Conclusions. Detailed assessment of ECGs, ambulatory ECGs, and coronary angiography can assist in identifying which children with HCM are at risk for sudden death.
|
Abbreviations and Acronyms
| | AECG | = ambulatory electrocardiogram | | CI | = confidence interval | | ECG | = electrocardiogram | | HCM | = hypertrophic cardiomyopathy | | QTc | = corrected QT interval | | RR | = relative risk | | VT | = ventricular tachycardia |
|
This article has been cited by other articles:
|
|
|
|
 
T. Rowland
Sudden Unexpected Death in Young Athletes: Reconsidering "Hypertrophic Cardiomyopathy"
Pediatrics,
April 1, 2009;
123(4):
1217 - 1222.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J P Kaski, M T Tome-Esteban, S Mead-Regan, A Pantazis, J Marek, J E Deanfield, W J McKenna, and P M Elliott
B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy
Heart,
October 1, 2008;
94(10):
1307 - 1311.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Ostman-Smith, G. Wettrell, B. Keeton, D. Holmgren, U. Ergander, S. Gould, C. Bowker, and M. Verdicchio
Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy
Eur. Heart J.,
May 1, 2008;
29(9):
1160 - 1167.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. D. Colan, S. E. Lipshultz, A. M. Lowe, L. A. Sleeper, J. Messere, G. F. Cox, P. R. Lurie, E. J. Orav, and J. A. Towbin
Epidemiology and Cause-Specific Outcome of Hypertrophic Cardiomyopathy in Children: Findings From the Pediatric Cardiomyopathy Registry
Circulation,
February 13, 2007;
115(6):
773 - 781.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Limongelli, T Miele, G Pacileo, G Di Salvo, P Calabro', R Ancona, S Gala, A Rea, M Verrengia, and R Calabro'
Heart rate variability is a weak predictor of sudden death in children and young patients with hypertrophic cardiomyopathy
Heart,
January 1, 2007;
93(1):
117 - 118.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Wren
Screening children with a family history of sudden cardiac death.
Heart,
July 1, 2006;
92(7):
1001 - 1006.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. McMahon, S. F. Nagueh, R. H. Pignatelli, S. W. Denfield, W. J. Dreyer, J. F. Price, S. Clunie, L. I. Bezold, A. L. Hays, J. A. Towbin, et al.
Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy
Circulation,
April 13, 2004;
109(14):
1756 - 1762.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Sakata, M Shimizu, H Ino, M Yamaguchi, H Terai, K Hayashi, M Kiyama, T Hayashi, M Inoue, and H Mabuchi
QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy
Heart,
August 1, 2003;
89(8):
882 - 886.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. W. Nugent, P. E.F. Daubeney, P. Chondros, J. B. Carlin, M. Cheung, L. C. Wilkinson, A. M. Davis, S. G. Kahler, C.W. Chow, J. L. Wilkinson, et al.
The Epidemiology of Childhood Cardiomyopathy in Australia
N. Engl. J. Med.,
April 24, 2003;
348(17):
1639 - 1646.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Marian
On predictors of sudden cardiac death in hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
March 19, 2003;
41(6):
994 - 996.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Butera, D Bonnet, J Kachaner, D Sidi, and E Villain
Heart rate variability in children with hypertrophic cardiomyopathy
Heart,
February 1, 2003;
89(2):
205 - 206.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mohlenkamp, W. Hort, J. Ge, and R. Erbel
Update on Myocardial Bridging
Circulation,
November 12, 2002;
106(20):
2616 - 2622.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Sudden Death in a Traveler Following Halofantrine Administration--Togo, 2000
JAMA,
April 11, 2001;
285(14):
1836 - 1836.
[Full Text]
[PDF]
|
|
|
|
